Healthcare -
Biotechnology - NASDAQ - US
$ 4.585
-1.98 %
$ 282 M
Market Cap
-4.55
P/E
GLUE - CHANGE IN WORKING CAPITAL
Change in Working Capital GLUE - Monte Rosa Therapeutics, Inc.
91.4 M
LAST VALUE
569.54%
2 YEAR CAGR
120.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR